{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:12:05Z","timestamp":1791223925722,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.schres.2012.06.036","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T15:18:45Z","timestamp":1342538325000},"page":"122-128","source":"Crossref","is-referenced-by-count":72,"title":["Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia"],"prefix":"10.1016","volume":"140","author":[{"given":"George","family":"Bartzokis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika P.","family":"Raven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan P.","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole R.","family":"Detore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Couvrette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie R.","family":"Casaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Subotnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith H.","family":"Nuechterlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2012.06.036_bb0005","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/archgenpsychiatry.2009.82","article-title":"Support for NRG1 as a susceptibility factor for schizophrenia in a northern Swedish isolated population","volume":"66","author":"Alaerts","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0010","series-title":"The Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.schres.2012.06.036_bb0015","series-title":"The Scale for the Assessment of Positive Symptoms (SAPS)","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.schres.2012.06.036_bb0020","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/jnr.20208","article-title":"Microarray analysis of postmortem temporal cortex from patients with schizophrenia","volume":"77","author":"Aston","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/glia.21122","article-title":"GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo","volume":"59","author":"Azim","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.schres.2012.06.036_bb0030","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4088\/JCP.v68n0808","article-title":"Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study","volume":"68","author":"Bai","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0035","first-page":"447","article-title":"Formation, maturation, and disorders of white matter","volume":"13","author":"Barkovich","year":"1992","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.schres.2012.06.036_bb0040","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0893-133X(02)00364-0","article-title":"Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation","volume":"27","author":"Bartzokis","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2012.06.036_bb0045","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2741\/3881","article-title":"Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments","volume":"16","author":"Bartzokis","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.schres.2012.06.036_bb0050","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.neuropharm.2012.01.015","article-title":"Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments","volume":"62","author":"Bartzokis","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2012.06.036_bb0060","first-page":"5","article-title":"Biological underpinnings of treatment resistance in schizophrenia: an hypothesis","volume":"37","author":"Bartzokis","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2012.06.036_bb0055","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1176\/appi.ajp.162.6.1229-a","article-title":"Reduced intracortical myelination in schizophrenia","volume":"162","author":"Bartzokis","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archpsyc.58.5.461","article-title":"Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study","volume":"58","author":"Bartzokis","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0006-3223(02)01835-8","article-title":"Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study","volume":"53","author":"Bartzokis","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2007.02.011","article-title":"Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia","volume":"93","author":"Bartzokis","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.schres.2009.06.014","article-title":"In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia","volume":"113","author":"Bartzokis","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2011.06.029","article-title":"Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory","volume":"132","author":"Bartzokis","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0080","article-title":"Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Pathophysiology and Antipsychotic Mechanism of Action","author":"Bartzokis","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.schres.2009.09.028","article-title":"Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder","volume":"115","author":"Beasley","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.schres.2012.06.036_bb0105","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1073\/pnas.1013535108","article-title":"DRD2\/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia","volume":"108","author":"Blasi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2012.06.036_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2009.09.019","article-title":"Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)","volume":"115","author":"Boter","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0115","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s11064-004-7039-x","article-title":"Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder","volume":"29","author":"Chambers","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuroscience.2011.10.051","article-title":"Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL\/6 mice","volume":"202","author":"Chandran","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2012.06.036_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2009.09.009","article-title":"Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia","volume":"115","author":"Cocchi","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0130","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.schres.2012.06.036_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2006.09.013","article-title":"Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates","volume":"89","author":"Emsley","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0140","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.mp.4001337","article-title":"Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins","volume":"8","author":"Flynn","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0145","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1073\/pnas.081071198","article-title":"Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia","volume":"98","author":"Hakak","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.schres.2012.06.036_bb0150","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.60.6.585","article-title":"Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia","volume":"60","author":"Ho","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0155","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1023\/A:1020981510759","article-title":"Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia","volume":"27","author":"Hof","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0160","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0006-3223(03)00237-3","article-title":"Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia","volume":"53","author":"Hof","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0165","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1176\/appi.ajp.2011.11010160","article-title":"Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study","volume":"168","author":"Howes","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tins.2009.05.007","article-title":"Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1","volume":"32","author":"Jaaro-Peled","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.schres.2012.06.036_bb0175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.schres.2005.06.007","article-title":"Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study","volume":"79","author":"Katsel","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737175.9.1.9","article-title":"Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness","volume":"9","author":"Keith","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.schres.2012.06.036_bb0190","series-title":"Clinical Neurology of Aging","first-page":"3","article-title":"Neuroanatomical and neuropathological changes during aging and dementia","author":"Kemper","year":"1994"},{"key":"10.1016\/j.schres.2012.06.036_bb0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mrm.1910200210","article-title":"Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain","volume":"20","author":"Koenig","year":"1991","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.schres.2012.06.036_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.b.30481","article-title":"Towards understanding the schizophrenia code: an expanded convergent functional genomics approach","volume":"144B","author":"Le-Niculescu","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.schres.2012.06.036_bb0215","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.4088\/JCP.1006e14","article-title":"Neurobiology and the natural history of schizophrenia","volume":"67","author":"Lieberman","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","article-title":"Time course and biologic correlates of treatment response in first-episode schizophrenia","volume":"50","author":"Lieberman","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0220","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0225","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4088\/JCP.08m04221","article-title":"Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response","volume":"70","author":"Lindenmayer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpsychires.2009.07.007","article-title":"Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia","volume":"44","author":"Martins-de-Souza","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/schbul\/18.3.387","article-title":"Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress","volume":"18","author":"Nuechterlein","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2012.06.036_bb0240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psychres.2004.04.018","article-title":"Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples","volume":"144","author":"Nuechterlein","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0245","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2975\/31.4.2008.340.349","article-title":"Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment","volume":"31","author":"Nuechterlein","year":"2008","journal-title":"Psychiatr. Rehabil. J."},{"key":"10.1016\/j.schres.2012.06.036_bb0250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","article-title":"Lipid composition of the normal human brain: gray matter, white matter, and myelin","volume":"6","author":"O'Brien","year":"1965","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0255","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1185\/03007990903149306","article-title":"Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry","volume":"25","author":"Olivares","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2012.06.036_bb0260","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.eurpsy.2008.12.002","article-title":"Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)","volume":"24","author":"Olivares","year":"2009","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2009.09.007","article-title":"Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia","volume":"1301","author":"Parlapani","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0270","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder","volume":"156","author":"Robinson","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0275","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","article-title":"Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder","volume":"161","author":"Robinson","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/B978-0-12-024910-7.50013-0","article-title":"Lipids in the nervous system of different species as a function of age: brain, spinal cord, peripheral nerve, purified whole cell preparations, and subcellular particulates: regulatory mechanisms and membrane structure","volume":"10","author":"Rouser","year":"1972","journal-title":"Adv. Lipid Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0285","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.schres.2012.06.036_bb0290","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1192\/bjp.bp.109.068577","article-title":"Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology","volume":"196","author":"Saravanan","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0295","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00401-008-0430-y","article-title":"Stereologic investigation of the posterior part of the hippocampus in schizophrenia","volume":"117","author":"Schmitt","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.schres.2012.06.036_bb0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2012.06.036_bb0310","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archpsyc.1995.03950220015005","article-title":"Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17","volume":"52","author":"Selemon","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0315","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/(SICI)1096-9861(19980316)392:3<402::AID-CNE9>3.0.CO;2-5","article-title":"Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method","volume":"392","author":"Selemon","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.schres.2012.06.036_bb0305","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-3223(99)00113-4","article-title":"Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure","volume":"46","author":"Selemon","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0320","doi-asserted-by":"crossref","first-page":"17288","DOI":"10.1073\/pnas.0406074101","article-title":"Neural synchrony indexes disordered perception and cognition in schizophrenia","volume":"101","author":"Spencer","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2012.06.036_bb0325","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/appi.ajp.2010.09010087","article-title":"Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia","volume":"168","author":"Subotnik","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0335","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(03)00181-6","article-title":"Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium","volume":"67","author":"Uranova","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0330","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/325789","article-title":"Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study","author":"Uranova","year":"2011","journal-title":"Schizophr. Res.Treat."},{"key":"10.1016\/j.schres.2012.06.036_bb0340","series-title":"Magnetic Resonance of Myelin, Myelination, and Myelin Disorders","author":"Valk","year":"1989"},{"key":"10.1016\/j.schres.2012.06.036_bb0345","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00340123","article-title":"MR imaging of the various stages of normal myelination during the first year of life","volume":"31","author":"van der Knaap","year":"1990","journal-title":"Neuroradiology"},{"issue":"Suppl. 4","key":"10.1016\/j.schres.2012.06.036_bb0350","first-page":"1","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0355","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-1781(98)00038-9","article-title":"Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I\/P)","volume":"79","author":"Ventura","year":"1998","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0360","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/174689","article-title":"Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders","author":"Vostrikov","year":"2011","journal-title":"Schizophr. Res.Treat."},{"key":"10.1016\/j.schres.2012.06.036_bb0365","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.04.014","article-title":"Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders","volume":"94","author":"Vostrikov","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0370","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2010.02.1068","article-title":"Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain","volume":"119","author":"Wang","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.06.036_bb0375","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1176\/appi.ajp.164.7.1082","article-title":"Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study","volume":"164","author":"Whitford","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.06.036_bb0380","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10198-009-0215-9","article-title":"The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden","volume":"11","author":"Willis","year":"2010","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.schres.2012.06.036_bb0385","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnbeh.2010.00008","article-title":"Behavioral and neurobiological changes in C57BL\/6 mouse exposed to cuprizone: effects of antipsychotics","volume":"4","author":"Xu","year":"2010","journal-title":"Front. Behav. Neurosci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412003532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412003532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T10:49:40Z","timestamp":1687603780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996412003532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":77,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0920996412003532"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2012.06.036","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}